RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Lillian Smith to Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Lillian Smith has written about Enzyme Inhibitors.
Lillian Smith
Connection Strength
0.458
Enzyme Inhibitors
  1. Smith L, Mosley J, Yates J, Caswell L. The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy. J Pharm Pharm Sci. 2016; 19(1):137-46.
    View in: PubMed
    Score: 0.458
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support